Sandoz, a key player in generic and biosimilar medicines, on Friday announced that the European Commission (EC) has granted marketing authorization for Afqlir (aflibercept) 2 mg vial kit and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback